PRODUCT DETAILS

About Eurepa-V 0.5/0.3 Tablet

REPAGLINIDE+VOGLIBOSE is a combination drug that belongs to the anti-diabetic class. It is primarily used to treat Type 2 diabetes. Type 2 diabetes is a common condition that causes the level of glucose (sugar) in the blood to become too high. It's a lifelong condition that can affect your everyday life. You may need to change your diet, take medicines, and have regular check-ups to lead a normal life.

REPAGLINIDE+VOGLIBOSE is composed of two medicines, namely Repaglinide and voglibose. Repaglinide increases the amount of insulin released by the pancreas by stimulating the pancreas to release insulin to your body and helps regulate the amount of glucose (sugar) in the blood. Voglibose helps control the amount of glucose (sugars) in the blood by inhibiting the intestinal enzyme (alpha-glucosidase) and delaying the digestion and absorption of carbohydrates in the intestine. Altogether, they prevent blood sugar from rising very high after meals.

Uses of Eurepa-V 0.5/0.3 Tablet

Used in the adult over 18 years of age and for treating patients with type 2 Diabetes.

Medicinal Benefits of Eurepa-V 0.5/0.3 Tablet

REPAGLINIDE+VOGLIBOSE is composed of two medicines, namely Repaglinide and voglibose. Repaglinide increases the amount of insulin released by the pancreas by stimulating the pancreas to release insulin to your body and helps regulate the amount of glucose (sugar) in the blood. Voglibose helps control the amount of glucose (sugars) in the blood by inhibiting the intestinal enzyme (alpha-glucosidase) and delaying the digestion and absorption of carbohydrates in the intestine. Altogether, they prevent blood sugar from rising very high after meals.

Directions for Use

Take this medication as directed by your doctor. The dosage is based on your medical condition and response to treatment. Use this medication regularly to get the most benefit from it. To help you remember, take it at the same time each day.

Side Effects of Eurepa-V 0.5/0.3 Tablet

• Low blood sugar (hypoglycemia)
• Upper respiratory infection
• Flu-like symptoms
• Back pain
• Joint pain
• Dizziness
• Skin rash or allergic reactions on the skin
• Indigestion or delayed digestion
• Loss of appetite
• Stomach ache or stomach upset
• Diarrhea
• Blurred vision
• Feeling of restlessness
• Feeling restless
• Weakness or fatigue

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug-Drug Interaction:

REPAGLINIDE+VOGLIBOSE interacts with Beta-blocker medications (e.g. metoprolol), Antidiabetic class of medications (e.g. metformin, insulin, sitagliptin, empagliflozin), and pain killers (e.g. aspirin).

Safety Advice

ALCOHOL

Limit alcohol while taking this medication because it can increase your risk of developing low blood sugar and a high ketone level.

DRIVING

You may experience blurred vision, dizziness, or drowsiness due to extremely low or high blood sugar. Do not drive, use machinery, or do any activity that requires alertness or clear vision until you are sure you can perform such activities safely.

LIVER

REPAGLINIDE+VOGLIBOSE to be taken with caution, especially if you have a history of liver diseases/conditions. 

KIDNEY

REPAGLINIDE+VOGLIBOSE to be taken with caution, especially if you have a history of Kidney diseases/conditions.